MedTrace Logo

16-Week Randomized Split-Face Efficacy Study of Cosmetic Formulations in Photoaged Pigmented Skin Subjects

NCT05160103 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2021-12-16

No results posted yet for this study

Summary

The objective of this study is to determine the efficacy of seven different formulations currently marketed and commercially available cosmetic products on skin tone evenness, post-inflammatory hyperpigmentation, and discrete pigmentation in females of Fitzpatrick skin types IV-VI.

Conditions

  • Aging Problems
  • Pigmentation

Interventions

OTHER

Cosmetic Formulations

Topical emulsions containing anti-aging ingredients

Sponsors & Collaborators

  • University of Cape Town, Groote Schuur Hospital

    collaborator UNKNOWN

  • Avon Products, Inc.

    lead INDUSTRY

Principal Investigators

  • Ardeshir Bayat, PhD · Professor & Co-Director, University of Cape Town

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-31
Primary Completion
2022-04-30
Completion
2022-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05160103 on ClinicalTrials.gov